spacer
home > pmps > winter 2001 > digital printing for pharmaceutical packaging - a customer's perspective
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digital Printing for Pharmaceutical Packaging - A Customer's Perspective

As digital printing becomes a more viable option for packaging, printing vendors are looking to the pharmaceutical industry as a lucrative market. There are several reasons why digital printing is suitable for pharmaceutical packaging:

The option of quick turnaround for printed materials is
especially attractive in an industry which is under increasing
pressure to bring products to launch

Frequent changes to packaging make any options which
reduce the inventory of printed materials very advantageous

Rapid safety changes are often necessary for
pharmaceutical products

While the cost of printed materials is not a major portion
of the cost of the product for large orders of pharmaceutical
products, this is not always true for short run, small volume
products.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Susan B. McNeely, Associate Engineering Consultant at Eli Lilly and Company in the US
Susan McNeely is a member of Eli Lilly and Company's corporate team, which provides technical support to Lilly packaging sites worldwide.
She is a Chemist by training and her previous assignments at Lilly include printed packaging development, pharmaceutical product development and quality assurance. Prior to joining Lilly, Susan worked at RCA and the University of Cincinnati Medical Center.

spacer
Susan B. McNeely
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera acquires Insight Product Development to strengthen its capabilities

“Every day at Nemera, we work to improve the lives of millions of patients worldwide by designing, developing and manufacturing innovative drug delivery devices. Our vision as a team is to become the most patient-centric drug delivery device company in the industry. We partner closely with our customers to deliver innovative and high quality devices, to ensure that patients will receive the best product and service possible” Marc Hämel, CEO
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement